Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study
- PMID: 3667621
Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study
Abstract
The kinetics of the activation of Glu- and Lys-plasminogen by single-chain urokinase (sc urokinase) derived from the transformed human kidney cell line TCL-598 have been studied and compared with two-chain urokinase (tc urokinase). Plasminogen activation was determined by the increase in fluorescence polarization of fluorescein-labeled aprotinin, a high affinity inhibitor of plasmin. This methodology allows plasmin generation by sc urokinase to be measured in functional isolation, with no interfering generation of tc urokinase, sc urokinase was found to activate plasminogen to plasmin with apparent Michaelis-Menten-type kinetics. The Km for Glu-plasminogen activation was 47.7 microM, with a catalytic constant of 2.91 min-1. Lys-plasminogen activation by sc urokinase was characterized by a Km of 11.7 microM and a kcat of 5.60 min-1. The Km values for the activation of Glu- and Lys-plasminogen by tc urokinase were found to be similar to those for activation by sc urokinase (36.8 and 9.0 microM, respectively), but the catalytic constants were higher at 36.0 and 118 min-1, respectively. Therefore, on the basis of the catalytic efficiency kcat/Km, sc urokinase seems to have 16-27-fold lower activity than tc urokinase. This activity of sc urokinase is in contrast to its lack of activity against a low molecular weight peptide substrate (less than 0.2% of the activity of sc urokinase). The activation of sc urokinase to tc urokinase by plasmin was also characterized (Km = 3.0 microM, kcat = 105 min-1). Using these data, it was possible to calculate the theoretical rate of plasminogen activation by sc urokinase in the absence of aprotinin, when tc urokinase is generated by the action of plasmin. The calculated rate was in good agreement with that determined experimentally using the chromogenic substrate D-Val-Leu-Lys-p-nitroanilide. These data demonstrate that sc urokinase has properties which distinguish it from conventional serine protease zymogens. The lack of activity against low molecular weight peptide substrates demonstrates the inaccessibility of the substrate-binding pocket. However, there is a moderate activity against plasminogen, suggesting that plasminogen may be acting as both an effector and a substrate for sc urokinase.
Similar articles
-
Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).Blood. 1987 Jan;69(1):22-6. Blood. 1987. PMID: 3790724
-
The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.J Biol Chem. 1983 Oct 25;258(20):12171-7. J Biol Chem. 1983. PMID: 6226655
-
A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.J Biol Chem. 1992 Aug 5;267(22):15289-92. J Biol Chem. 1992. PMID: 1639775
-
New approaches to thrombolytic therapy.Arteriosclerosis. 1984 Nov-Dec;4(6):579-85. doi: 10.1161/01.atv.4.6.579. Arteriosclerosis. 1984. PMID: 6439177 Review.
-
Plasminogen activation on the cell surface.Front Biosci. 2002 Jan 1;7:d244-55. doi: 10.2741/A724. Front Biosci. 2002. PMID: 11779703 Review.
Cited by
-
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.J Cell Biol. 1989 May;108(5):1987-95. doi: 10.1083/jcb.108.5.1987. J Cell Biol. 1989. PMID: 2523891 Free PMC article.
-
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.Proc Natl Acad Sci U S A. 1990 Mar;87(6):2230-4. doi: 10.1073/pnas.87.6.2230. Proc Natl Acad Sci U S A. 1990. PMID: 2138329 Free PMC article.
-
Steady states and dynamics of urokinase-mediated plasmin activation in silico and in vitro.Biophys J. 2011 Oct 19;101(8):1825-34. doi: 10.1016/j.bpj.2011.08.054. Biophys J. 2011. PMID: 22004735 Free PMC article.
-
Increased plasminogen binding is associated with metastatic breast cancer cells: differential expression of plasminogen binding proteins.Br J Cancer. 1998 May;77(10):1586-97. doi: 10.1038/bjc.1998.261. Br J Cancer. 1998. PMID: 9635833 Free PMC article.
-
Biochemical and structural analyses suggest that plasminogen activators coevolved with their cognate protein substrates and inhibitors.J Biol Chem. 2019 Mar 8;294(10):3794-3805. doi: 10.1074/jbc.RA118.005419. Epub 2019 Jan 16. J Biol Chem. 2019. PMID: 30651349 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous